| |
| |
|
| Insider
Information: |
Chiniara Ellen |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
55,960 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,960 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alere Inc |
ALR |
GC, Chief Ethics Offic... |
2017-10-03 |
0 |
2008-06-30 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP & Chief Legal Offi... |
2021-07-21 |
0 |
2018-02-28 |
0 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
|
2024-03-01 |
55,960 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALR |
Alere Inc |
GC, Chief Ethics Officer&Sec |
• – – |
2017-08-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,667 |
34,927 |
0 |
- |
|
| ALR |
Alere Inc |
GC, Chief Ethics Officer&Sec |
• – – |
2017-08-31 |
4 |
D |
$49.46 |
$106,982 |
D/D |
(2,163) |
32,764 |
0 |
- |
|
| ALR |
Alere Inc |
GC, Chief Ethics Officer&Sec |
• – – |
2017-10-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(32,764) |
0 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & General Counsel |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,344 |
8,344 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & General Counsel |
• – – |
2019-02-28 |
4 |
D |
$132.92 |
$84,138 |
D/D |
(633) |
7,711 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & General Counsel |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,250 |
15,961 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2019-12-15 |
4 |
A |
$93.86 |
$5,068 |
D/D |
54 |
24,952 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
26,161 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2020-03-02 |
4 |
D |
$90.54 |
$114,352 |
D/D |
(1,263) |
24,898 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2020-12-15 |
4 |
A |
$95.53 |
$5,350 |
D/D |
56 |
43,060 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,965 |
62,917 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2020-12-16 |
4 |
D |
$157.96 |
$3,145,457 |
D/D |
(19,913) |
43,004 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,321 |
62,381 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
54,469 |
116,850 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Chief Legal Officer |
• – – |
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(116,850) |
0 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
37,500 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-01-04 |
4 |
S |
$22.58 |
$74,416 |
D/D |
(3,295) |
34,205 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Legal Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
21,755 |
55,960 |
0 |
- |
|
43 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
